SOLARES-PsO-1SCD-044 for Moderate to Severe Plaque Psoriasis

This study is all about testing a potential new treatment called SCD-044 for moderate to severe plaque psoriasis. Psoriasis is a skin condition that causes red, itchy scaly patches, most commonly on the knees, elbows, trunk and scalp. The study aims to find out if SCD-044 is safe and effective in treating this condition. It's important because current treatments may not work for everyone or may have side effects, so finding new options is crucial for improving care and quality of life for people with psoriasis. In this study, participants are randomly assigned to receive either SCD-044 or a placebo, which looks like the real treatment but doesn't contain any active ingredients. Neither the participants nor the researchers know who is receiving which, to ensure the results are not influenced by expectations. The main goal is to measure if at least 75% of the participants' Psoriasis Area and Severity Index (PASI) score improves. The PASI score ranges from 0 to 4, with higher scores indicating more severe disease. The study will calculate the percentage of participants who show improvement.